Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederroche.com
Roche Media News
Get the latest updates from Roche Media News directly as they happen.
Follow now 295 followers
Latest posts
Last updated 18 days ago
Roche to present new and encouraging long-term follow-up data across broad haematology portfolio at ASH 2024
18 days ago
Basel, 05 November 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced...
Roche presents new data at CTAD, demonstrating its growing momentum in diagnostics for Alzheimer’s disease
23 days ago
New data highlight the potential of the Roche Elecsys® Amyloid Plasma Panel...
New England Journal of Medicine publishes landmark phase III results for Roche’s Itovebi, showing more than doubling of progression-free survival in certain type of HR-positive advanced breast cancer
23 days ago
ItovebiTM (inavolisib)-based regimen demonstrated a statistically significant and clinically meaningful benefit, reducing...
[Ad hoc announcement pursuant to Art. 53 LR] Roche’s strong sales growth of 9% (CER) continues in the third quarter of 2024; Group sales increase 6% in the first nine months
about 1 month ago
Group sales grew by 6%1 at constant exchange rates (CER) (2% in...
Roche’s Vabysmo improved vision in underrepresented populations with diabetic macular edema (DME) in a first-of-its-kind study
about 1 month ago
The ELEVATUM study showed clinically meaningful improvement in vision and reduction in...
Majority of children with spinal muscular atrophy (SMA) treated with Roche’s Evrysdi are able to sit, stand and walk independently, two-year data demonstrate
about 1 month ago
Positive data confirm Evrysdi efficacy and safety in children first treated pre-symptomatically...
FDA approves Roche’s Itovebi, a targeted treatment for advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation
about 1 month ago
Approval is based on Phase III INAVO120 results, showing the Itovebi™ (inavolisib)-based...
Roche obtains CE certification for the first companion diagnostic to identify patients with gastric and gastroesophageal junction cancer eligible for targeted treatment with VYLOY
about 1 month ago
The new VENTANA CLDN18 (43-14A) RxDx Assay helps fulfil an unmet medical...
Positive phase III results for Roche’s Gazyva/Gazyvaro show superiority to standard therapy alone in people with lupus nephritis
about 2 months ago
Positive phase III results for Roche’s Gazyva/Gazyvaro show superiority to standard therapy...
Roche launches the first test to use its breakthrough TAGS technology for high throughput, simultaneous detection of 12 respiratory viruses
about 2 months ago
New TAGS (Temperature-Activated Generation of Signal) technology enables up to 15 targets...
WHO endorses dual-stain cytology (CINtec PLUS) testing in its cervical cancer prevention guidelines, advancing patient care and underlining Roche’s role in pioneering cervical cancer solutions
2 months ago
Roche’s CINtec PLUS Cytology is the only FDA-approved and CE-marked dual-stain test...
Positive phase III results show Xofluza significantly reduces the transmission of influenza viruses
2 months ago
Data from the CENTERSTONE study shows single-dose Xofluza reduces transmission of influenza...